Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

CAR T cells produced in vivo using modified mRNA treat cardiac injury

CAR T cells produced in vivo using modified mRNA treat cardiac injury

Researchers discover a crucial and exploitable vulnerability in diffuse large B cell lymphomas

Researchers discover a crucial and exploitable vulnerability in diffuse large B cell lymphomas

Researchers develop new CAR T cells that act as a "micropharmacy"

Researchers develop new CAR T cells that act as a "micropharmacy"

Biochemical signals sent from cell to cell play a key role in deciding their fate

Biochemical signals sent from cell to cell play a key role in deciding their fate

Researchers develop novel technique to monitor remote immune mechanisms

Researchers develop novel technique to monitor remote immune mechanisms

Driving up the immune response at tumor site may help boost immunotherapy

Driving up the immune response at tumor site may help boost immunotherapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

Researchers identify a new approach to triggering differentiation in acute myeloid leukemia

Researchers identify a new approach to triggering differentiation in acute myeloid leukemia

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Finding better treatments to eradicate infection caused by H. pylori bacterium

Finding better treatments to eradicate infection caused by H. pylori bacterium

Genomic changes in advanced tumors reveal interactions with treatment

Genomic changes in advanced tumors reveal interactions with treatment

Using a new genetic technology to decipher intratumoral heterogeneity

Using a new genetic technology to decipher intratumoral heterogeneity

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Study reveals how two separate DNA changes may predict aggressive childhood leukemias

Study reveals how two separate DNA changes may predict aggressive childhood leukemias

Researchers develop method to preserve high-quality cultured stem cells for a long time

Researchers develop method to preserve high-quality cultured stem cells for a long time

Study: Biomarker can predict response to immunotherapies in breast cancer patients

Study: Biomarker can predict response to immunotherapies in breast cancer patients

Nanobody mapping using NMR proves a promising alternative for therapeutic use

Nanobody mapping using NMR proves a promising alternative for therapeutic use

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.